![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
more_vert
Follicular Lymphoma
1. Positive Loncastuximab & Rituximab Results in R/R Follicular Lymphoma | Juan Alderuccio, MD | #ASH24 Video
2. Rituximab for Low Tumor Burden Follicular Lymphoma | Noriko Fukuhara MD, PhD | #ASH24 Video
3. CAR-T Cell Therapy for Transformed Follicular Lymphoma | Matthew Cortese, MD | #ASH24 Video
4. Odronextamab as First-Line Therapy in Follicular Lymphoma | Rueme Birhiray, MD | #ASH24 Video
5. Allogeneic & Autologous Stem Cell Transplant for Follicular Lymphoma | Yasmina Serroukh, MD | #ASH24 Video
6. Promising Results for CAR-T Cell therapy for Follicular Lymphoma | Matthew Frank, MD, PhD | #ASH24 Video
Positive Loncastuximab & Rituximab Results in R/R Follicular Lymphoma | Juan Alderuccio, MD | #ASH24
2 years ago
Lesson Description
Dr. Juan Alderuccio from the Sylvester Comprehensive Cancer Center discusses an ongoing study of loncastuximab and rituximab in the treatment of relapsed/refractory patients with high-risk follicular lymphoma.